checkAd
    Startseite > Aktien > AbCellera Biologics > Nachrichten
    AbCellera Biologics Aktie
    3,9200
     
    USD
    -2,97 %
    -0,1200 USD
    Letzter Kurs 02:00:00 Nasdaq
    3,9200
     
    USD
    3.400 STK
    Geldkurs 31.05.24
    3,9300
     
    USD
    200 STK
    Briefkurs 31.05.24
    ISIN: CA00288U1066 · WKN: A2QKXS · SYM: ABCL · Kanada ·

    Neueste Nachrichten

    AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
    28.05.24 · Business Wire (engl.) · AbCellera Biologics
    AbCellera Reports Q1 2024 Business Results
    07.05.24 · Business Wire (engl.) · AbCellera Biologics
    AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies
    01.05.24 · Business Wire (engl.) · AbCellera Biologics
    AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024
    08.04.24 · Business Wire (engl.) · AbCellera Biologics
    AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024
    03.04.24 · Business Wire (engl.) · AbCellera Biologics
    AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024
    19.03.24 · Business Wire (engl.) · AbCellera Biologics
    AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions
    11.03.24 · Business Wire (engl.) · AbCellera Biologics
    AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024
    05.03.24 · Business Wire (engl.) · AbCellera Biologics
    AbCellera Announces Resignation of Board Member
    23.02.24 · Business Wire (engl.) · AbCellera Biologics
    AbCellera to Present at Upcoming Investor Conferences in March
    23.02.24 · Business Wire (engl.) · AbCellera Biologics
    AbCellera Reports Full Year 2023 Business Results
    20.02.24 · Business Wire (engl.) · AbCellera Biologics
    AbCellera to Report Full Year 2023 Financial Results on February 20, 2024
    23.01.24 · Business Wire (engl.) · AbCellera Biologics